SI2144934T1 - Protitelesa proti IL-25 - Google Patents

Protitelesa proti IL-25

Info

Publication number
SI2144934T1
SI2144934T1 SI200831698A SI200831698A SI2144934T1 SI 2144934 T1 SI2144934 T1 SI 2144934T1 SI 200831698 A SI200831698 A SI 200831698A SI 200831698 A SI200831698 A SI 200831698A SI 2144934 T1 SI2144934 T1 SI 2144934T1
Authority
SI
Slovenia
Prior art keywords
antibodies against
antibodies
Prior art date
Application number
SI200831698A
Other languages
English (en)
Inventor
Andrew Neil James Mckenzie
Sarah Ballantyne
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of SI2144934T1 publication Critical patent/SI2144934T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200831698A 2007-04-18 2008-04-17 Protitelesa proti IL-25 SI2144934T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US91247407P 2007-04-18 2007-04-18
GBGB0707505.4A GB0707505D0 (en) 2007-04-18 2007-04-18 Antibodies against il-25
EP08737025.0A EP2144934B1 (en) 2007-04-18 2008-04-17 Antibodies against il-25
PCT/GB2008/001365 WO2008129263A1 (en) 2007-04-18 2008-04-17 Antibodies against il-25

Publications (1)

Publication Number Publication Date
SI2144934T1 true SI2144934T1 (sl) 2016-12-30

Family

ID=38135020

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200831698A SI2144934T1 (sl) 2007-04-18 2008-04-17 Protitelesa proti IL-25

Country Status (32)

Country Link
US (1) US8206717B2 (sl)
EP (1) EP2144934B1 (sl)
JP (1) JP5366930B2 (sl)
KR (1) KR101605861B1 (sl)
CN (1) CN101711256B (sl)
AU (1) AU2008240436B2 (sl)
BR (1) BRPI0810418A8 (sl)
CA (1) CA2684492C (sl)
CO (1) CO6260104A2 (sl)
CR (1) CR11079A (sl)
CY (1) CY1118244T1 (sl)
DK (1) DK2144934T3 (sl)
EA (1) EA018073B1 (sl)
EC (1) ECSP099726A (sl)
ES (1) ES2604255T3 (sl)
GB (1) GB0707505D0 (sl)
GT (1) GT200900271A (sl)
HN (1) HN2009003038A (sl)
HR (1) HRP20161548T1 (sl)
HU (1) HUE030935T2 (sl)
IL (1) IL201552A (sl)
LT (1) LT2144934T (sl)
MX (1) MX2009011234A (sl)
MY (1) MY148451A (sl)
NI (1) NI200900189A (sl)
NZ (1) NZ581178A (sl)
PL (1) PL2144934T3 (sl)
PT (1) PT2144934T (sl)
RS (1) RS55401B1 (sl)
SI (1) SI2144934T1 (sl)
UA (1) UA100377C2 (sl)
WO (1) WO2008129263A1 (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0817891D0 (en) * 2008-09-30 2008-11-05 Medical Res Council Antibodies against il-25
US8574582B2 (en) * 2008-10-31 2013-11-05 Janssen Biotech, Inc. Methods for mediating fibrotic response
GB0905972D0 (en) * 2009-04-06 2009-05-20 Medical Res Council Antibodies against IL-17BR
EP2477647B1 (en) 2009-09-14 2016-01-13 The Regents of the University of Colorado Modulation of yeast-based immunotherapy products and responses
ES2656336T3 (es) 2010-03-30 2018-02-26 Janssen Biotech, Inc. Anticuerpos de IL-25 humanizados
WO2013119419A1 (en) * 2012-02-08 2013-08-15 North Carolina State University Treatment of allergic diseases with recombinant antibodies
JP6250351B2 (ja) * 2013-09-30 2017-12-20 シスメックス株式会社 好酸球性気道炎症に関する情報の取得方法およびそのような情報を取得するためのマーカー
CN103792375B (zh) * 2014-01-29 2017-07-07 华中科技大学同济医学院附属同济医院 外周血白细胞介素25水平在哮喘分型中的应用及分型方法
AU2015321517B2 (en) * 2014-09-23 2021-02-18 Regeneron Pharmaceuticals, Inc. Anti-IL-25 antibodies and uses thereof
WO2017160587A1 (en) * 2016-03-16 2017-09-21 Abeome Corporation Neutralizing monoclonal antibodies to il-25 and uses thereof
WO2018017864A2 (en) * 2016-07-20 2018-01-25 Oncomed Pharmaceuticals, Inc. Pvrig-binding agents and uses thereof
WO2018018082A1 (en) 2016-07-26 2018-02-01 The Australian National University Immunostimulatory compositions and uses therefor
EP3538558A4 (en) 2016-11-09 2020-07-15 North Carolina State University TREATMENT OF ALLERGIC DISEASES WITH A CHIMERAL PROTEIN
CN112638940B (zh) * 2018-11-19 2022-09-30 苏州鑫康合生物医药科技有限公司 抗-il-25抗体及其用途
GB202018015D0 (en) 2020-11-16 2020-12-30 Res & Innovation Uk Composition and methods for the treatment of intestinal cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9015198D0 (en) * 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US6569645B2 (en) * 1999-05-14 2003-05-27 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
CN1289668C (zh) * 2003-06-12 2006-12-13 北京安波特基因工程技术有限公司 一种用于抗体改形的体外分子定向进化方法
ES2533970T3 (es) 2005-03-08 2015-04-16 Aptose Biosciences Inc. Uso de interleucina 17E para el tratamiento de cáncer
US20070237763A1 (en) 2005-10-06 2007-10-11 Baylor Research Institute Compositions and methods for the treatment of cancer
GB0817891D0 (en) 2008-09-30 2008-11-05 Medical Res Council Antibodies against il-25

Also Published As

Publication number Publication date
EA200901421A1 (ru) 2010-10-29
HRP20161548T1 (hr) 2016-12-30
GT200900271A (es) 2010-11-03
JP5366930B2 (ja) 2013-12-11
CA2684492C (en) 2015-11-24
DK2144934T3 (en) 2016-12-12
GB0707505D0 (en) 2007-05-30
EA018073B1 (ru) 2013-05-30
MY148451A (en) 2013-04-30
JP2010524450A (ja) 2010-07-22
HN2009003038A (es) 2011-11-11
RS55401B1 (sr) 2017-04-28
US8206717B2 (en) 2012-06-26
ES2604255T3 (es) 2017-03-06
PT2144934T (pt) 2016-12-02
AU2008240436B2 (en) 2011-03-17
IL201552A (en) 2015-08-31
CO6260104A2 (es) 2011-03-22
CY1118244T1 (el) 2017-06-28
EP2144934A1 (en) 2010-01-20
KR101605861B1 (ko) 2016-03-24
CN101711256A (zh) 2010-05-19
CA2684492A1 (en) 2008-10-30
UA100377C2 (en) 2012-12-25
ECSP099726A (es) 2010-01-29
EP2144934B1 (en) 2016-08-24
NZ581178A (en) 2012-01-12
KR20100021569A (ko) 2010-02-25
IL201552A0 (en) 2010-05-31
CN101711256B (zh) 2013-10-16
LT2144934T (lt) 2016-12-27
WO2008129263A1 (en) 2008-10-30
US20100129380A1 (en) 2010-05-27
AU2008240436A1 (en) 2008-10-30
MX2009011234A (es) 2010-02-18
NI200900189A (es) 2010-09-13
PL2144934T3 (pl) 2017-07-31
BRPI0810418A8 (pt) 2018-12-11
CR11079A (es) 2010-03-03
HUE030935T2 (en) 2017-06-28
BRPI0810418A2 (pt) 2014-10-14

Similar Documents

Publication Publication Date Title
IL201552A0 (en) Antibodies against il-25
GB0708002D0 (en) Antibodies
HRP20150224T1 (en) Anti mif antibodies
HK1185622A1 (en) Axl antibodies axl
HK1136970A1 (en) Penta-specific antibody
EP3064512C0 (en) ANTIBODIES AGAINST CLDN6
EP2138576A4 (en) ANTI-CLAUDIN-4 ANTIBODY
GB0821100D0 (en) Antibodies
SI2200700T1 (sl) Nova protitelesa
EP2172483A4 (en) ANTI-MUC17 ANTIBODY
EP2337798A4 (en) BSA-SPECIFIC ANTIBODIES
HK1154022A1 (en) Antibodies against il-25 il-25
GB0718737D0 (en) Antibodies
IL205073A0 (en) Anti-bst2 antibody
GB0702888D0 (en) Novel Antibodies
ZA201006099B (en) Anti-tyrp1 antibodies
ZA201007976B (en) Anti-pirb antibodies
GB0818356D0 (en) Antibodies
GB0911770D0 (en) Antibody
GB0724185D0 (en) Antibodies
GB0806230D0 (en) Antibodies
GB0823562D0 (en) Antibodies
GB0817621D0 (en) Antibody
GB0817622D0 (en) Antibody